SLNO

Soleno to Participate in the 31st Annual Oppenheimer Healthcare Conference

Soleno Therapeutics (SLNO) Is in Oversold Territory: What's Next?

Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results

Soleno Therapeutics Provides Recap of Key Opinion Leader Webinar on DCCR for Treatment of Prader-Willi Syndrome

Soleno Therapeutics: Could Be Big Fish In The Small Pond

Soleno Therapeutics to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference

Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome